Your go-to source for real-time financial news and market analysis. Powered by AI. Covering earnings, economic events, and corporate news.
Nike’s CEO sees the business in the “middle innings” of a turnaround, despite disappointing financial results expected. Shares are cheap
Dr. Alissa Fitzgerald sold 59,316 shares of Rigetti Computing on Jan. 2, 2026, for ~$1.3 million, representing 63.11% of her
Bitcoin is often compared to “digital gold” and is mostly uncorrelated with major asset classes. Gold stablecoins, pegged to gold’s
Cardano price is down 2% over the past 24 hours, trending lower since January 6, but remains flat over the
The FlexShares Global Quality Real Estate Index Fund (GQRE) and iShares Global REIT ETF (REET) both target global real estate
The FlexShares Global Quality Real Estate Index Fund (GQRE) and iShares Global REIT ETF (REET) offer exposure to global real
Meta Platforms (META) faces a delay in the international rollout of its Ray-Ban Display smart glasses due to high demand
The iShares Semiconductor ETF (SOXX) and State Street Technology Select Sector SPDR ETF (XLK) offer different levels of sector focus
President of EverCommerce, Matthew David Feierstein, sold 25,000 shares directly for about $250,515 in total over three days, representing 1.1%
Starknet, an Ethereum layer‑2 scaling network, experienced its second major network disruption in 2025, requiring a block reorganization to rollback
Anne from Pittsburgh discovered $209,000 in credit card debt hidden by her husband of 19 years. She lacked access to
Ubiquiti saw impressive growth in 2025, with shares rallying 66.7%. The founder and CEO owns 93% of shares, leading to
JPMorgan Chase & Co. reports a surge in US corporate bonds on the brink of junk status, totaling $63 billion,
The cost of health insurance in America has risen over 50% since 2010, according to the Federal Reserve Bank of
The Treasury Department is facing competition from companies issuing their own bonds, possibly leading to higher rates, says Apollo Chief
AbbVie Inc. (NYSE:ABBV) is one of the best performing pharma stocks in 2025 but was downgraded to Peer Perform from
Eli Lilly and Company (NYSE:LLY) is acquiring Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company focused on oral therapies for inflammatory
Amarin Corporation plc (NASDAQ: AMRN) is one of the best performing pharma stocks in 2025, achieving positive cash flow in
Teva Pharmaceutical Industries Limited (NYSE: TEVA) has been identified as one of the best performing pharma stocks in 2025. Truist
Amneal Pharmaceuticals, Inc. (AMRX) is among the best performing pharma stocks in 2025, with Truist raising its price target to
Indivior PLC (NASDAQ:INDV) is among the best performing pharma stocks in 2025, with a full-year 2026 financial guidance predicting total
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) is among the best-performing pharma stocks in 2025. AMX0318, a long-acting GLP-1 receptor antagonist, is a
Biogen Inc. (NASDAQ:BIIB) is one of the best performing pharma stocks in 2025. Truist raised the price target to $190
Microsoft Corporation (NASDAQ:MSFT) was discussed by Jim Cramer for its downward trajectory and stock price drop from last year. The
JPMorgan Chase & Co. (NYSE: JPM) is a stock Jim Cramer highlighted as undervalued. Cramer praised the bank’s strong franchise
